169 related articles for article (PubMed ID: 34043181)
1. Protective Effect of Aldo-keto Reductase 1B1 Against Neuronal Cell Damage Elicited by 4'-Fluoro-α-pyrrolidinononanophenone.
Morikawa Y; Miyazono H; Kamase K; Suenami K; Sasajima Y; Sato K; Endo S; Monguchi Y; Takekoshi Y; Ikari A; Matsunaga T
Neurotox Res; 2021 Aug; 39(4):1360-1371. PubMed ID: 34043181
[TBL] [Abstract][Full Text] [Related]
2. α-Pyrrolidinononanophenone provokes apoptosis of neuronal cells through alterations in antioxidant properties.
Matsunaga T; Morikawa Y; Kamata K; Shibata A; Miyazono H; Sasajima Y; Suenami K; Sato K; Takekoshi Y; Endo S; El-Kabbani O; Ikari A
Toxicology; 2017 Jul; 386():93-102. PubMed ID: 28578026
[TBL] [Abstract][Full Text] [Related]
3. α-Pyrrolidinononanophenone derivatives induce differentiated SH-SY5Y neuroblastoma cell apoptosis via reduction of antioxidant capacity: Involvement of NO depletion and inactivation of Nrf2/HO1 signaling pathway.
Sakai Y; Egawa D; Hattori J; Morikawa Y; Suenami K; Takayama T; Nagai A; Michiue T; Ikari A; Matsunaga T
Neurotoxicology; 2024 Jan; 100():3-15. PubMed ID: 38040126
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic mechanism in human brain microvascular endothelial cells triggered by 4'-iodo-α-pyrrolidinononanophenone: Contribution of decrease in antioxidant properties.
Sakai Y; Taguchi M; Morikawa Y; Miyazono H; Suenami K; Ochiai Y; Yanase E; Takayama T; Ikari A; Matsunaga T
Toxicol Lett; 2022 Feb; 355():127-140. PubMed ID: 34863860
[TBL] [Abstract][Full Text] [Related]
5. 4'-Iodo-α-Pyrrolidinononanophenone Provokes Differentiated SH-SY5Y Cell Apoptosis Through Downregulating Nitric Oxide Production and Bcl-2 Expression.
Sakai Y; Morikawa Y; Nagao Y; Hattori J; Suenami K; Yanase E; Takayama T; Ikari A; Matsunaga T
Neurotox Res; 2022 Oct; 40(5):1322-1336. PubMed ID: 35834058
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
Ebert B; Kisiela M; Wsól V; Maser E
Chem Biol Interact; 2011 May; 191(1-3):239-49. PubMed ID: 21215737
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells.
Matsunaga T; Kawabata S; Yanagihara Y; Kezuka C; Kato M; Morikawa Y; Endo S; Chen H; Iguchi K; Ikari A
Chem Biol Interact; 2019 Dec; 314():108839. PubMed ID: 31563593
[TBL] [Abstract][Full Text] [Related]
8. Tolrestat acts atypically as a competitive inhibitor of the thermostable aldo-keto reductase Tm1743 from Thermotoga maritima.
Zhang C; Min Z; Liu X; Wang C; Wang Z; Shen J; Tang W; Zhang X; Liu D; Xu X
FEBS Lett; 2020 Feb; 594(3):564-580. PubMed ID: 31573681
[TBL] [Abstract][Full Text] [Related]
9. Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives.
Liu J; Wen G; Cao D
Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):246-53. PubMed ID: 19522700
[TBL] [Abstract][Full Text] [Related]
10. Facilitation of 9,10-phenanthrenequinone-elicited neuroblastoma cell apoptosis by NAD(P)H:quinone oxidoreductase 1.
Matsunaga T; Kamase K; Takasawa H; Yamaji Y; Endo S; El-Kabbani O; Ikari A
Chem Biol Interact; 2018 Jan; 279():10-20. PubMed ID: 29108775
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
Zhang L; Zhang H; Zhao Y; Li Z; Chen S; Zhai J; Chen Y; Xie W; Wang Z; Li Q; Zheng X; Hu X
FEBS Lett; 2013 Nov; 587(22):3681-6. PubMed ID: 24100137
[TBL] [Abstract][Full Text] [Related]
12. Availability of aldo-keto reductase 1C3 and ATP-binding cassette B1 as therapeutic targets for alleviating paclitaxel resistance in breast cancer MCF7 cells.
Matsunaga T; Horinouchi M; Saito H; Hisamatsu A; Iguchi K; Yoshino Y; Endo S; Ikari A
J Biochem; 2023 Mar; 173(3):167-175. PubMed ID: 36413758
[TBL] [Abstract][Full Text] [Related]
13. Identification of aldo-keto reductases as NRF2-target marker genes in human cells.
Jung KA; Choi BH; Nam CW; Song M; Kim ST; Lee JY; Kwak MK
Toxicol Lett; 2013 Mar; 218(1):39-49. PubMed ID: 23305850
[TBL] [Abstract][Full Text] [Related]
14. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of rat aldo-keto reductase (AKR1C15) on endothelial cell damage elicited by 4-hydroxy-2-nonenal.
Matsunaga T; Shinoda Y; Inoue Y; Endo S; El-Kabbani O; Hara A
Chem Biol Interact; 2011 May; 191(1-3):364-70. PubMed ID: 21187080
[TBL] [Abstract][Full Text] [Related]
16. Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential.
Khayami R; Hashemi SR; Kerachian MA
J Cell Mol Med; 2020 Aug; 24(16):8890-8902. PubMed ID: 32633024
[TBL] [Abstract][Full Text] [Related]
17. Lowering of brain endothelial cell barrier function by exposure to 4'-iodo-α-pyrrolidinononanophenone.
Sakai Y; Taguchi M; Morikawa Y; Suenami K; Yanase E; Takayama T; Ikari A; Matsunaga T
Chem Biol Interact; 2022 Sep; 364():110052. PubMed ID: 35872046
[TBL] [Abstract][Full Text] [Related]
18. Stereoselectivity of Aldose Reductase in the Reduction of Glutathionyl-Hydroxynonanal Adduct.
Balestri F; Barracco V; Renzone G; Tuccinardi T; Pomelli CS; Cappiello M; Lessi M; Rotondo R; Bellina F; Scaloni A; Mura U; Del Corso A; Moschini R
Antioxidants (Basel); 2019 Oct; 8(10):. PubMed ID: 31652566
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.
Matsunaga T; Yamaji Y; Tomokuni T; Morita H; Morikawa Y; Suzuki A; Yonezawa A; Endo S; Ikari A; Iguchi K; El-Kabbani O; Tajima K; Hara A
Free Radic Res; 2014 Nov; 48(11):1371-85. PubMed ID: 25156503
[TBL] [Abstract][Full Text] [Related]
20. Aldo-keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells.
Lyon RC; Li D; McGarvie G; Ellis EM
Neurochem Int; 2013 Jan; 62(1):113-21. PubMed ID: 23084985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
